CAM
BHVN
Cormorant Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-184,894
| Closed | -$28M | – | 80 |
|
|
2022
Q3 | $28M | Hold |
184,894
| – | – | 1.95% | 18 |
|
|
2022
Q2 | $26.9M | Buy |
184,894
+104,894
| +131% | +$15.3M | 2.04% | 17 |
|
|
2022
Q1 | $9.49M | Buy |
+80,000
| New | +$9.49M | 0.73% | 42 |
|
|
2021
Q2 | – | Sell |
-200,000
| Closed | -$13.7M | – | 134 |
|
|
2021
Q1 | $13.7M | Sell |
200,000
-225,000
| -53% | -$15.4M | 0.3% | 58 |
|
|
2020
Q4 | $36.4M | Sell |
425,000
-75,000
| -15% | -$6.43M | 0.87% | 28 |
|
|
2020
Q3 | $32.5M | Sell |
500,000
-100,000
| -17% | -$6.5M | 1.25% | 25 |
|
|
2020
Q2 | $43.9M | Sell |
600,000
-275,551
| -31% | -$20.1M | 1.67% | 17 |
|
|
2020
Q1 | $29.8M | Sell |
875,551
-124,449
| -12% | -$4.23M | 1.38% | 18 |
|
|
2019
Q4 | $54.4M | Sell |
1,000,000
-281,400
| -22% | -$15.3M | 2.17% | 13 |
|
|
2019
Q3 | $53.5M | Sell |
1,281,400
-268,600
| -17% | -$11.2M | 3.25% | 6 |
|
|
2019
Q2 | $67.9M | Buy |
1,550,000
+450,000
| +41% | +$19.7M | 3.9% | 6 |
|
|
2019
Q1 | $56.6M | Buy |
1,100,000
+450,000
| +69% | +$23.2M | 3.83% | 6 |
|
|
2018
Q4 | $24M | Buy |
650,000
+390,000
| +150% | +$14.4M | 1.95% | 14 |
|
|
2018
Q3 | $9.76M | Sell |
260,000
-24,735
| -9% | -$929K | 0.63% | 32 |
|
|
2018
Q2 | $11.3M | Hold |
284,735
| – | – | 0.83% | 34 |
|
|
2018
Q1 | $7.34M | Sell |
284,735
-13,068
| -4% | -$337K | 0.55% | 29 |
|
|
2017
Q4 | $8.04M | Buy |
+297,803
| New | +$8.04M | 0.84% | 27 |
|